NasdaqCM - Nasdaq Real Time Price USD
Sangamo Therapeutics, Inc. (SGMO)
0.4526
-0.0074
(-1.61%)
As of 11:56:26 AM EDT. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-67,139
-67,139
-224,842
-223,627
-233,251
Investing Cash Flow
37,524
37,524
153,531
59,285
248,199
Financing Cash Flow
28,377
28,377
14,588
84,660
32,858
End Cash Position
43,418
43,418
46,704
101,944
180,372
Capital Expenditure
-267
-267
-21,155
-20,171
-23,278
Issuance of Capital Stock
28,991
28,991
15,106
84,869
27,099
Free Cash Flow
-67,406
-67,406
-245,997
-243,798
-256,529
12/31/2021 - 4/6/2000
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
XLO Xilio Therapeutics, Inc.
0.9711
-15.55%
CTMX CytomX Therapeutics, Inc.
2.1950
-12.18%
CRVS Corvus Pharmaceuticals, Inc.
3.5950
-7.58%
IOVA Iovance Biotherapeutics, Inc.
1.6850
-5.87%
CNSP CNS Pharmaceuticals, Inc.
1.1702
-13.96%
HEPA Hepion Pharmaceuticals, Inc.
0.3180
0.00%
TOVX Theriva Biologics, Inc.
0.5848
+4.42%
SRPT Sarepta Therapeutics, Inc.
35.72
-1.33%
QURE uniQure N.V.
12.59
-1.72%
HCWB HCW Biologics Inc.
10.01
-0.41%